Neuland Laboratories Ltd — Quarterly Results & Earnings

₹12027.00

-1.94%

Profit Growth YoY194.91%Latest quarter

Sales Growth YoY65.45%Latest quarter

Sales CAGR 5Y14.13%5 year compound

Profit CAGR 5Y66.88%5 year compound

📋

Quarterly Performance

YoY Profit Growth+194.91%

🔥 Exceptional growth

YoY Sales Growth+65.45%

🔥 Exceptional growth

OPM 5Y Average

Operating profit margin

22.21%

EPS Growth 5Y

66.88%

Interest Coverage

Higher = safer debt servicing

18.79

ROE

14.83%

ROCE

18.66%

💡

Growth Analysis

Neuland Laboratories Ltd reported YoY profit growth of 194.91% and revenue growth of 65.45% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 14.13% and profits at 66.88% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Neuland Laboratories Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.